Team access only.
Four questions, answered plainly: who else is fighting for this market, whether we can actually win it, how big our edge really is, and exactly what to do this year. The honest headline up top: our edge is real and rare, but it comes from WHERE we stand, and there is a clock on it. This year is the window.
tip Every glowing ? opens a plain-English deep-dive. Tap them.
Our competitors are mostly tech companies that pointed great data tools at big hospitals and insurers. The healthcare experts built consulting services, not software. Reddenda is the rare team with both skills, aimed at the one customer nobody else will serve: the small independent practice.
The government forced insurers to publish what they pay every provider, so that data is now public. Everyone in this market is racing to turn it into leverage: proof a practice can take to a payer and say "pay me more." The prize is the provider who wants a better rate. The giants all chased big hospitals and health systems. We picked the slice they ignore: the small practice that has never had a tool like this.
Four kinds of players. Notice the empty lane at the bottom.
| Player type | Who they sell to | Their price | Do they want OUR customer? |
|---|---|---|---|
| Tech data companies techie Serif, Trilliant |
Other software companies and big enterprises | Sell the raw data feed; some give it away free | No. They sell the data, not the answer. They do not help anyone negotiate. |
| Healthcare insiders insider Aroris, consultants |
Hospitals and large groups | A cut of whatever they recover (success fee) | No. Small practices are too small to bother with, and their model cannot scale down. |
| Big billing platforms incumbent athenahealth, Tebra, Waystar |
The practices they already host | A percent of collections, or $1,000+/mo | No. They cannot fight the payers their own business depends on. |
| Reddenda both the empty lane |
Small independent practices and their billers | $0 to $997, flat | Yes. That is the entire company. Nobody else is standing here. |
Two kinds of companies are trying to win this market. Tech people who must LEARN healthcare, and healthcare people who must BUILD technology. Whoever clears both jobs first wins. So which job is harder?
| The Techies techie engineers coming into healthcare | The Insiders insider healthcare experts coming into tech | |
|---|---|---|
| Great at | Building software, parsing giant data files, shipping fast. | Knowing how billing, payers, and contracts really work. |
| Struggle with | They do not know what a small biller actually negotiates, or how to stay on the right side of the law. | Turning that know-how into real software instead of a hands-on service. |
| How they cope | Sell the raw data and let the customer figure out the rest. | Stay a consulting shop and charge a cut of what they recover. |
| Real examples | Serif (built its core in a few months). Trilliant (gives billions of rates away free). | Aroris (success-fee negotiation service). MD Clarity (only shipped a product after hiring a tech chief). |
| Can they win our lane? | Only if they ALSO learn the hard domain. Most swerve away. | Only if they ALSO build real software. Most never do. |
The data files are genuinely huge and messy. But it is a normal engineering job with a finish line. Serif built its core in a few months. Trilliant gives billions of rates away free. So this wall gets cheaper to climb every year.
What Trilliant did. In late 2025 Trilliant Health took the raw hospital price files every U.S. hospital must publish, cleaned and stitched them, and gave the whole thing away, three moves in a row: a free AI chatbot (Oria, Oct 16), then a free repository of 5B+ raw rates (Nov 18), then a single free "data lake" you can query from your laptop with 6B+ negotiated rates across 5,000+ hospitals (Dec 4). No servers, no data team needed.
Why would anyone give that away? Because the giveaway is the business. Three motives stacked: lead-gen (free data is the best top-of-funnel into their paid analytics), land-and-expand (the free tier answers easy questions, anything deeper pushes you to the paid product), and salting the earth (if the raw data is free, a rival who sells raw data has nothing left to sell).
What "the wall" is. The wall is the old barrier of acquiring and parsing those giant public rate files, hunting them down source by source and wrestling messy formats into something usable. That used to need a real data-engineering team.
Why it gets cheaper every year. Free lakes like Trilliant's, plus Serif, plus ever-cheaper compute and AI, mean anyone can now clear that wall in an afternoon. So raw rate-data access is becoming a commodity, and a commodity is not a moat.
The honest nuance. Trilliant's free lake is the hospital-published side; our core is the payer-published side (the insurer Transparency-in-Coverage files). Cousins, not twins. But the same wall is falling on both sides at once, so the lesson holds.
The punchline for us. Since the data itself is commoditizing, our durable edge cannot be "we have the data." It has to be the action layer (the signable negotiation memo) and the history our customers create by using it, which no free lake contains. That is the whole point of the "Our Edge" tab.
The facts are easy: what a billing code is, how the fee schedule works, a weekend of reading. So people underestimate the ONE hard part: knowing what a small biller actually negotiates, what number moves a payer, and how to stay compliant.
Fifteen real players. For each one: the actual tools they sell, what they do with the payer-rate data, and how they price it. The pattern to notice (spelled out under the table): almost nobody serves the small independent practice, and not one of them is flat, self-serve pricing.
Everyone here is one of three kinds of company, and each kind has a built-in reason it cannot serve our customer:
1. Rate-data sellers (Serif, Payerset, Trilliant, Turquoise, Clarify, Definitive, PayerPrice). They clean the public rate files and sell the data, feeds, APIs, dashboards, or give it away to sell analytics on top. They stop at the data. They hand you a spreadsheet, not a signed rate increase, and they sell to other software companies and big enterprises, not to a solo practice.
2. Contract + recovery tools (Rivet, MD Clarity, Aroris). These get closest to us. But they run on a practice's OWN already-signed contracts to find underpayments, aimed at hospitals and groups, or sold as a done-for-you service on a success fee. None is a self-serve memo a solo practice runs before it signs.
3. Billing + RCM platforms (athenahealth, Tebra, Waystar, Candid, Adonis). They run the whole billing office. Most never touch the public rate data at all, and they are paid a percent of what you collect, so they cannot pick a fight with the payers their revenue depends on.
The lane nobody fills: flat-priced, self-serve, no-PHI rate leverage aimed straight at the small independent practice. That is the entire company.
Clean the public rate files and sell the data, or give it away to sell analytics. Stop at the spreadsheet.
Digitize your OWN contracts, find underpayments, negotiate for you. Hospitals/groups or success-fee service.
Run the whole billing office. Most never touch the rate data, and charge a percent of collections.
| Company | The tools they actually sell | What they do with the rate data | Pricing model |
|---|---|---|---|
| Turquoise Health both LOW enterprise rate DB + AI contract tools | Clear Rates Data (their master rate database) · Market Intelligence (benchmarking dashboards) · Contract Intelligence (AI reads your payer contracts and models what-if rate scenarios) · Precision Contracting (premium: rate modeling + denials by contract) · AskTQ (AI chat over it) · plus free consumer price-shopping and Medicare/out-of-network pricers | Cleans the public hospital + payer files into one proprietary "Clear Rates" dataset, then sells it three ways: analytics dashboards, AI contract-negotiation modeling, and a free consumer/compliance layer for lead-gen. Now expanding into processing the payments themselves. | Quote-gated enterprise annual. Tiered (Analyze → Contracts → Precision), unlimited users, priced by company type, coverage, and number of contracts. ~$95M raised. Consumer tools free. |
| Serif Health techie MED rate-data wholesaler / API | Signal (no-code app: type a provider/payer/code, see negotiated rates + percentiles) · Signal Ask (AI copilot, beta) · Peer Benchmarks · APIs / Neuron (embed live rates into your own software) · FindCare + Provider Directory APIs · Data Delivery (bulk feed to your warehouse) | The "pick-and-shovel" supplier: ingests payer files at huge scale (they cite 350B+ rates a month), normalizes them, and resells the data as a search app, APIs, and bulk feeds to 200+ other software companies. Sells the raw material, not the answer. | Quote-gated. No public prices. Custom by product (Signal / API / Data Delivery) and data-access level. Free sample dataset to try. |
| Trilliant Health insider MED analytics + free data lake | Oria (free public AI chatbot for hospital prices) · Free DuckDB data lake (6B+ rates given away at $0) · Rate Benchmarking (paid) · Health Plan Price Transparency Analytics (paid) · National Provider Directory (2.9M+) · Longitudinal Patient Journeys (~300M patients) · Workbench + Explorer | Runs a two-sided model: gives billions of hospital rates away free (chatbot + data lake) to own the top of funnel, then joins payer files to a provider directory + 300M-patient claims and sells the analytics. The giveaway is the marketing (see the Trilliant dive in "Techies vs Insiders"). | Free tier (Oria + the 6B-rate lake) + quote-gated enterprise analytics subscriptions. No public dollar figures. |
| Payerset data MED rate-data infrastructure | Rate Explorer (self-serve app to compare negotiated rates across payers/providers) · Data Lake (piped into your warehouse) · Standard Charges module (hospital chargemaster analysis) · Price Transparency Algorithm (their ghost-rate-stripping cleaner) · free Payer Compliance Scorecard | Refines-and-resells the public files: ingests 100% of published payer + hospital MRFs, de-duplicates and strips "ghost rates," then sells the cleaned data as a self-serve app or a raw warehouse feed. A cleaner data wholesaler. | Published pricing (rare here). Rate Explorer priced by hospital bed count; Data Lake is enterprise. One of the few that posts a price. |
| PayerPrice data MED rate benchmarking + free tools | Rate Benchmarking (type a code, see what everyone in your market is paid, by NPI/Tax ID) · Fee Schedule Downloads · Market Outlier Detection · Medicare Comparison (rate as % of Medicare) · Contracted Rates API · Data Share (Snowflake/Databricks) · free public rate explorer + Medicare lookup + 835/837 converter + a negotiation-letter template | Same raw material as us: structures the public files into a searchable rate database and sells lookups, benchmarks, and a feed. Closest to a small-practice benchmark, but stops at "here is the number" plus a generic letter template, no signable memo, no accumulated history. | Quote-gated usage-based, set on an onboarding call. Free entry layer (free tools + 100 free API searches). |
| Rivet Health both HIGH RCM suite (now Zelis-owned) | Payer Performance (store your contracts, benchmark your rates vs the market, model renegotiations) · Revenue Diagnostics (AI cash forecast) · Underpayments Management (groups underpaid claims into recovery "projects") · Claim Resolution / Resolve · Denials Prevention · Patient Pricing · MRF solution | The closest to us. Uses the public TiC files as the external benchmark to compare a practice's own contracted rates against the market, then drives underpayment recovery. But it is a full RCM suite for practices/groups, not a self-serve one-page memo, and it was just absorbed by Zelis (a payer-side giant). | Quote-gated annual SaaS. Third-party directories report a starting price around ~$6,000/yr, custom-quoted. |
| MD Clarity insider MED underpayment + estimates | RevFind (stores your signed contracts, catches underpaid/denied claims) · PayerMonitor (AI reads messy payer contracts) · Clarity Flow (patient cost estimates + Good Faith Estimates) · Underpayment + Denial Recovery Services (done-for-you) | Does not use the public rate data. Runs entirely on the provider's OWN private contracts and claims to find underpayments, then software plus a human recovery service chase the money. A recovery tool, not a pre-signing negotiation tool. | Quote-gated annual (unlimited users). Recovery services are typically a % of the money recovered. |
| Aroris Health insider MED done-for-you negotiation | Aroris360 (their "Revenue Governance OS": contract library, benchmark engine, rate-case builder) · Contract Optimization (audit that flags underpaid codes) · Contract Negotiation (human negotiators do it for you) · Live Claims Monitoring · free 60-second revenue assessment | Pools payer rates into a proprietary benchmark they keep in-house to power their own service; they do not sell or give away the data. The product is really the human negotiator, backed by the benchmark. | Success fee. A cut of the incremental revenue they negotiate above your current baseline. Not flat, and structurally can't scale down to a solo practice. |
| Clarify Health insider LOW enterprise analytics | Clarify Atlas (the data engine: 300M+ patient lives + rate data) · Meridian (referral/network growth for systems) · Clarify Rates / Rates IQ (the rate-adjacent one) · Networks · Performance IQ · Access (pharma) · Growth | Uses the public rate files as ONE input into a big AI enrichment-and-analytics engine (fused with ~500TB of claims), sold to payers, health systems, and pharma. Rate data is an ingredient, not the product; no small-practice surface. | Quote-gated enterprise. No list prices anywhere. |
| Definitive Healthcare data LOW commercial intelligence DB | Atlas Dataset (master reference DB) · HospitalView / PhysicianView / ClinicView etc (profiles of every provider) · Atlas All-Payor Claims (billions of claims) · Populi + Monocl + Carevoyance (sales-targeting suites) | A "ZoomInfo for healthcare" plus a claims engine. Sells subscription access to provider profiles and claims analytics for sales and marketing targeting. Not a rate-negotiation product at all; adjacent, not competing. | Quote-gated annual, priced per named user, a la carte or bundled. |
| athenahealth incumbent MED EHR + billing platform | athenaOne (all-in-one EHR + billing + engagement) · athenaClinicals (EHR) · athenaCollector (billing/PM) · athenaEDI (clearinghouse, 375M+ transactions/yr) · Patient Estimates · Marketplace (add-ons) · AI documentation | Does not touch the public rate data as a product. Runs the practice's billing office end to end. Its only price-transparency page is athenahealth complying with the rule for its own plan. | Percent of collections ("no long-term contracts"), quote-gated. Paid a cut of what you collect, so it cannot fight your payers. |
| Tebra incumbent LOW small-practice OS | EHR / EHR+ · Practice Management · Billing & Payments · Contract Rates / Fee Schedules (you type in your OWN rates) · Underpayment monitoring · Patient Engagement · Practice Marketing (ex-PatientPop) · AI staff/reviews | Never touches the public rate data. The only rates in the product are the ones the practice manually types in. Underpayment monitoring compares paid vs your own entered rate. Same customer as us (small practices), opposite tool. | Quote-gated per-provider monthly subscription (non-clinical staff free). Bundled/module sales via demo. |
| Waystar incumbent LOW enterprise RCM + clearinghouse | Claim Manager (clearinghouse) · Denial + Appeal Management (AI writes appeals) · Authorization · Eligibility · Patient Estimation · Price Transparency · Coverage Detection · Charge Integrity · AltitudeAI and ~20 more modules | Uses contract/rate data internally to power estimates and payment matching, not as a product. A giant enterprise revenue-cycle platform for health systems; the small practice is far below its floor. | Quote-gated enterprise, priced by provider count + claim volume + modules, plus clearinghouse per-transaction fees. |
| Candid Health techie MED automated billing (ex-Palantir) | Automation & AI Rules Engine (reverse-engineers each payer's claim quirks) · Smart Claim Autocorrection · Analytics · AR / Denial Automation · RCM API · EDI/ERA + Eligibility · human RCM support | Does not touch the public rate data. Runs on the provider's own claims and the payer's 835/ERA responses to make billing "touchless." A modern billing engine, not a rate-leverage tool. | Percent of collections (~3%, or 3% + ~$6/claim with coding), quote-gated. Raised ~$99.5M. |
| Adonis techie LOW AI revenue-cycle automation | Adonis Intelligence (watches the whole revenue cycle) · Adonis AI Agents (autonomous bots: verify coverage, work denials) · Adonis Orchestration · Epic Connection Hub integration | Does not touch the public rate data. Works on the provider's own claims, remits, and EHR data (e.g. via Epic) to catch denials/underpayments with AI agents. Enterprise health systems and groups, not solo practices. | Quote-gated enterprise, "ROI/outcome-aligned." Raised ~$95M. |
"Touches the public rate data" = uses the same federal Transparency-in-Coverage files Reddenda uses. Six of these fifteen do not touch it at all; they run on the practice's own billing data. "Quote-gated" means they publish no price and make you book a sales call. Not one of the fifteen offers flat, self-serve pricing to a solo practice. That empty lane is the company.
Short version: the funded ones moved UP and SIDEWAYS. Nobody came DOWN to the small-practice lane.
We own seven assets. Only some are real edges. Here is the honest verdict on each.
| Our asset | Is this a real edge? | Why |
|---|---|---|
| The rate-data platform (our owned data lake) | Nice, but everyone can get it | Anyone can buy the same public files. BUT we own our copy, so each report costs us pennies while a rival pays a data bill every month. |
| The RateScore method (local peer median, P90 target) | Nice, but everyone can get it | A clear, trustworthy way to score a rate. Any funded rival can copy the math. |
| The action layer (the negotiation memo, the app)
The action layer, in full: what it is, what we have, why it wins, how to do it deep dive
What it is. Everything a practice DOES with the rate data after they see it. Today that means the signable Counteroffer / Leverage Memo (a one-page document a practice takes to a payer to ask for a higher rate) and the app they generate it in, backed by the RateScore. It is the layer between "here is your rate" and "here is a better rate, signed." What we have NOW. The memo and the app are live, v1. A practice can already run a Snapshot, get a RateScore, and generate a memo. So this is not a from-scratch build, and the table saying "build now" does not mean the tool does not exist. Then why does it say "build now"? Because the tool is not the moat, the accumulated history behind it is. A rate lookup is forgettable and copyable day one. But two seasons of a practice's OWN confirmed renewal dates, filed appeals, past memos, and RateScore trend is expensive to walk away from and worthless to a rival who starts at zero. "Build now" means start accumulating that history now, not rebuild the memo. Why it is our strongest edge. Of everything we own, this is the one asset a funded clone cannot buy, copy, or download. They can clone the pricing page and buy the rates in an afternoon (see the Trilliant dive). They cannot copy a customer's two-year outcome history. Every cycle a practice stays, its exit cost compounds and the clone's catch-up cost rises. How we do it, the actual playbook:
| Have v1. The moat is what it ACCUMULATES | The memo and app already exist. The durable part is not the tool, it is the per-NPI history each cycle leaves behind (confirmed dates, past memos, appeal outcomes, RateScore trend) that a rival starts from zero on. It only locks in customers who are ON it, so sign them fast and keep that history un-exportable. |
| Counter-positioning (flat price, no patient data, self-serve) | Real and durable | The giants literally cannot copy this without breaking their own business. This is the one edge that holds today. |
| The channel (billing / RCM / MSO partners) | A real edge we must BUILD now | One partner brings a whole roster of practices, and the relationship locks. Not built yet. |
| The private data pool (customers' real rates) | Could become huge later | The one dataset no public file has. Only works once enough customers contribute. Build it behind a lawyer's review. |
| RateScore as a brand | Could become huge later | Brand takes years. Give the score away free now, cash it in as a standard later. |
Not one of the seven is impossible to copy on its own. The defensible thing is the SET, not any single row. That is the next table.
Seven things that, together, make us hard to copy. Any rival has one or two. Only our column is all yes.
Reddenda is the only company that checks all seven boxes. The next best competitor checks two.
| The 7 things | Reddenda | Turquoise | Serif | athena | Rivet |
|---|---|---|---|---|---|
| A signable negotiation document | yes | no | no | no | no |
| Small-practice self-serve | yes | no | no | yes | yes |
| No patient data needed | yes | yes | yes | no | no |
| Flat pricing, never a percent | yes | no | no | no | yes |
| The renewal clock | yes | no | no | no | no |
| The RateScore | yes | no | no | no | no |
| Private, customer-created data | yes | no | no | no | no |
We are far behind on money and brand. We are far ahead in the one lane their money cannot buy into. Four lines:
We are not data-poor. Reddenda runs an owned estate of 41 datasets normalized across 9 domains (commercial rates, Medicare and GPCI, hospital charges, Medicaid, and more) on a public-data cost base, plus a multi-billion-row rate lake we own outright, so a report costs us pennies while a rival pays a data bill every month. Most competitors bring two to four siloed datasets. So we are not behind on data. We are behind on money and brand, which is a different problem.
Raw scale is not the moat anyway. Trilliant just gave 6B+ rates away free and Serif processes 350B+ rates a month. If "the most rates" were the edge, they would have won already. They did not, because access is a commodity (see the Trilliant dive). Chasing "more rates than Turquoise" would be fighting on the one axis that does not matter.
The data we ARE ahead on is the data nobody can buy. Our real data edge is forward-looking: the private pool our customers create (their real contracted rates and de-identified paid amounts) and the confirmed renewal-date graph. Neither exists in any public file or any rival's lake. FAIR Health built the largest private US claims database (53B+ records) exactly this way, from voluntarily contributed data no one else could reconstruct.
So the honest gap is two words: money and brand. Not data. We answer money with a pennies-per-report cost base that funds growth without outside capital, and we seed brand by giving the RateScore away free now and cashing it as the standard later.
One flat, self-serve ladder from a $0 score to a $997 audit that no competitor can copy without breaking their own business, sold on the renewal clock, engineered so every purchase leaves behind history a rival starts from zero on. We never charge a percent of your collections, and we never haggle.
This is not a guess. It is the winner of a 10-model pricing war room, scored 1 to 100 by a final judge and stress-tested by a devil's advocate. The winning design is called ALMANAC at 90 out of 100, and it beat nine alternatives including a pure membership, a per-report "Carfax" model, a channel-only model, and a single-price model. What follows is that model in plain English.
Honest floor, stated first: every dollar below is modeled, not guaranteed. Today the product has near-zero revenue and the payment rail needs one fix before any of it is real (see the Sprint 0 gate at the bottom). The design is finished; the collection is not.
Every rung is a flat dollar figure a buyer can read without a sales call. The price rises with the depth of the artifact, never with a percent of your money.
| Rung | Price | What you get | Its job in the engine |
|---|---|---|---|
| Free Snapshot | $0 | See if a rate gap exists, in about 15 seconds, in your browser. No email, no card, no PHI. | The free RateScore. Top of funnel and the brand seed (the "check your credit score" move). |
| Leverage / Counteroffer Memo | $299 once | One signable one-page memo for a single payer negotiation. | The first artifact that creates history. The cheapest way in. |
| Practice Audit | $997 / $697 founding | Full audit across payers, plus the memo and a strategy. | The core paid artifact. The anchor value. |
| Pro | $399/mo | Continuous monitoring, alerts, saved snapshots, renewal support, the accumulating RateScore timeline. | The switching-cost engine. Every month deepens the per-NPI history. |
| Growth (multi-NPI / billing-co / MSO) | Schedule a call | Multi-location, billing-company, and MSO roll-ups. Never gated, never priced inline. | The channel and org lane. One signature onboards a whole roster. |
Each was scored 1 to 100 and attacked by a devil's advocate. The flat-ladder-plus-organs design took the top score. Here is why the obvious alternatives lose.
All ten cleared the legal floor (flat USD, never a percent). They differ on how they grow and how simple they are to buy:
The verdict: commit to ALMANAC, graft DOCKET's per-contract expansion, borrow DESK's advisory naming and PAR's never-a-percent promise. Confidence roughly 85 to 88 percent.
| How the market prices | Who does it | Solo practice can buy? | Why we are better |
|---|---|---|---|
| Quote-gated enterprise (book a call, custom annual) | Turquoise, Serif, Clarify, Definitive, Waystar, Adonis, most of the field | no | A solo practice never gets past the sales gate. We post the price and let them self-serve in minutes. |
| Percent of collections | athenahealth, Candid | no | Taking a cut of your money means they cannot fight your payers, and it is a legal minefield. We charge a flat fee and stay clean. |
| Success fee (a cut of the increase) | Aroris | no | Success fees cannot scale down to a $299 memo; the economics only work on big hospital contracts. Our flat memo does. |
| Free data, paid analytics | Trilliant, PayerPrice free tier | sort of | They hand you a spreadsheet. We hand you a signable memo and keep your history. The data is the commodity; the action is the product. |
| Flat, self-serve ladder ($0 to $997, never a percent) | Reddenda, alone | yes | The only model a solo practice can actually buy, that a giant cannot copy, and that stays legal by construction. |
Build up each practice's own history (its payers, rates, confirmed dates, past memos) so leaving means starting over from scratch.
Sell to the billing and RCM firms that already run dozens of practices, and onboard their whole roster at once.
Let customers share their real, contracted rates in exchange for better benchmarks, creating a dataset nobody can buy.
Make "what's my RateScore?" the normal question a practice asks, the way people ask about their credit score.
Use our pennies-per-report cost to price below any funded rival and outlast them, funding growth with no outside money.
Every durable advantage has a life-stage where it can be built, and the window closes. The whole discipline is to point our energy at the powers winnable right now, seed the ones that pay off later, and never mistake the floor for the edge.
This comes from Hamilton Helmer's "7 Powers," the standard playbook for durable advantage. His key finding: each kind of moat can only be built at a specific moment, and if you miss the window it is gone.
Origination powers (counter-positioning, a cornered resource) are what a startup is born with. We hold counter-positioning already: flat price and no PHI, which the giants cannot copy without breaking their own model.
Takeoff powers (switching costs, network effects, scale economics) can ONLY be won during fast growth, right now, in the next few quarters, before a funded copycat starts its own clock. None of ours are banked yet. This is the entire job this year.
Stability powers (brand, process) come last. You cannot buy brand late, so you seed it for free now (give the RateScore away) and harvest it once you have a base. Process power (our ghost-rate filtering) is table stakes: keep it sharp, never claim it keeps a funded rival out.
The failure mode Helmer names is spending the takeoff window on the wrong power: chasing brand while unknown, or trying to bolt on switching cost after rivals are entrenched. So we build switching cost and the flywheel NOW, seed brand free, and refuse the distractions.
| Stage | Powers you can build here | What we do about it now |
|---|---|---|
| Origination (day one) | Counter-positioning, cornered resource | Already held: no-PHI, flat price the giants cannot copy. The private-data flywheel is the cornered resource, still to build. |
| Takeoff (right now, 2 to 6 quarters) | Switching costs, network economies, scale economies | The entire job this year. None banked yet. This is the winnable set, and the window is open now, before a funded clone starts its own clock. |
| Stability (later) | Branding, process power | Seed the RateScore-as-standard brand now, harvest later. Process power (ghost-filtering) is table stakes, never the edge. |
One connected sequence. Each step feeds the next, and each one banks a specific power. Nothing here waits on outside money.
A moat is as much what you say no to as what you build. Every one of these is a tempting trap that would cost us the takeoff window.
| We refuse | Because |
|---|---|
| An enterprise / committee sales motion | That is the incumbents' cornered ground ($75K to $350K, procurement-heavy). Chasing it starves the wedge that is actually ours. |
| A second parallel "big bet" | One transformation at a time. Two tear a two-person company apart. The channel is the one; everything else stays small. |
| Any PHI / BAA feature | It forfeits the no-PHI counter-position, the day-one power the whole strategy rests on. PHI-bound rivals cannot follow us there; do not join them. |
| Leaky metering (pure pay-per-report, full export, no stored history) | It destroys the switching cost. Never price in a way that makes leaving cheap. |
| Claiming "we have the data" is the moat | Access is a commodity (see the Trilliant dive). Claiming it invites the exact rebuttal a funded rival will make. It is the floor, not the edge. |
| Brand spend before the base exists | Brand is a stability power you cannot buy early. Seed the standard for free now, harvest the brand later off the installed base. |
Each phase: one action, one result. Nothing more.
| Phase | When | Do this | The result |
|---|---|---|---|
| Phase 0 | weeks 0 to 4 | Prove the plumbing works and start measuring: stand up the KPIs and smoke-test the payment rail weekly. | You can see what is compounding, and you know the payment rail actually works. |
| Phase 1 | months 1 to 4 | Land 3 to 5 billing-company partners, timed to renewal season, and flood them with our documents. | A whole roster of practices onboarded at once, each one piling up its own history. |
| Phase 2 | months 3 to 9 | Open the private data pool, behind a lawyer's review. | You start building the one dataset nobody can buy. |
| Phase 3 | months 6 to 12+ | Publish the proof and watch the lead compound. | By the time a copycat is visible, it starts at zero on everything that matters. |
| The risk | So we do this |
|---|---|
| Practices are lazy about negotiating (37% never do) the biggest one | Make the free score effortless; sell through billing companies who are paid to care. |
| Our own rail never works, near-zero revenue today | One goal first: 10 paying practices kept 60 days. Smoke-test the payment rail every week. |
| A funded rival drops down to our price | Run the season now; bank the customer history they cannot copy; hold the price floor. |
| Serif arms a copycat with data | We never sold data as the edge. Our customer-created data is not on Serif's shelf. |
| A billing platform bundles a rival's widget | Be the tool billing companies white-label FIRST. |
| Our rate data goes stale (esp. renewal dates) | Turn published dates into customer-confirmed dates we own; re-check the data quarterly. |
We scored ten different strategies against each other, stress-tested the winner against the real market, and studied the companies that won this exact game before us. Here is what came back.
Not dethroned by any alternative. It is the only plan that plays the hand we actually hold: an owned data lake that costs us pennies per report, a rare mix of healthcare and engineering skill, two operators plus AI, aimed at the one lane where being richer does not help our rivals win.
Every path Reddenda could take, scored out of 70 on revenue ceiling, defensibility, speed, cost efficiency, team fit, downside safety, and future options. The order is decisive.
| Rank | Strategy | Score | Why it wins or loses |
|---|---|---|---|
| 1 | Own the small-practice lane recommended | 56 | Strong on all three things a two-person-plus-AI team actually has: defensibility, cost efficiency, and team fit. Plays our real hand. |
| 2 | Start with one specialty first | 52 | Fastest to real traction: a narrow beam cuts through apathy. Too small alone, lethal as an add-on. We graft this in. |
| 3 | Do the negotiation as a flat-fee service | 43 | Fastest real cash and makes paid proof, but two operators cap it and it does not build a moat. A season-one bridge only. |
| 4 | Channel-only white-label | 42 | Partners carry the selling, but pure white-label gives up our direct lock-in. The stress test promotes the channel to our spine. |
| 5 | Build to be acquired early | 36 | The buyout wave is real, but building TO flip starves the moat. Keep as a near-free backup posture, never the plan. |
| 6 | Give everything away free | 34 | Right instinct (free the score, we already do), wrong scope. Free-everything at zero revenue starves a bootstrap. |
| 7 | Sell the raw data (arms dealer) | 31 | Monetizes the one asset that is NOT a moat and is commoditizing anyway. It arms our own copycats. Refuse. |
| 8 | Raise venture and blitzscale | 28 | Raising at zero revenue is a dilution trap and blitzscale destroys our pennies-per-report weapon. Refuse now. |
| 9 | Go up-market / enterprise | 25 | Marches into the fortified square we are counter-positioned OUT of, with none of the money that square rewards. Refuse. |
| 10 | Sell to the insurers | 22 | Worst option: it inverts the very thing that makes us special to chase a market owned by giants. Refuse. |
Point the first renewal season at behavioral health: it is paid roughly $120 to $135 where BCBS pays $180 to $210 on the same session code, it has a federal parity law on our side, and its practices are small and scattered.
Promote the billing-company channel from one focus to the MAIN motion. Keep clean books and clear data ownership so being bought is a cheap backup plan.
Our private, de-identified rate pool is a licensing revenue line, the way pharma paid Phreesia (25 to 35% of its revenue) and PBMs paid GoodRx (82% of its contribution). Lawyer-reviewed, no patient data.
As of January 2026, only 36.1% of physicians still own their practice. The rest have been bought up.
Either the billing company's professional negotiator buys, or a practice owner clears the small cheap-purchase bar. Proven or disproven in one season, by Oct 31, 2026.
3 to 5 channel partners sign and keep white-labeling us instead of building it themselves. Measured by signed agreements, not interest.
We sell to the groups buying practices up, not fight them door to door. Insist on pure direct-to-independent and the shrinking market beats us.
| How we could still lose, even doing everything right | Odds | Why it is easy to miss |
|---|---|---|
| Owners are simply too apathetic to act, and the market to sell to collapses | HIGHEST | A demand problem. It shows up as healthy interest but flat purchases, invisible on any competitor board. |
| The market consolidates away faster than we can sign practices | MEDIUM | The most under-rated risk. 81,100 fewer independent practices than 2018. A market problem, not a competitor one. |
| Channel partners refuse, or build their own version | MEDIUM | The firm with the claim stream could buy rate data and build its own benchmark. We have a named sensor for this. |
| A funded billing-automation company adds negotiation first | MEDIUM | Candid or Adonis reaching down into our lane, 12 to 24 months out. We watch their job postings. |
Five companies won Reddenda's shape (an ignored small-business segment, a data-plus-action product, done cheaply through a channel or a data flywheel). Their moves collapse into one sequence.
The real fix at the execution level is not a new strategy, it is measurement. The plan was under-instrumented, not under-designed. Here is the dashboard we run the business against.
A practice counts as "compounding" when it has BOTH a confirmed renewal date AND at least one document we have generated for it. It rises only when the channel, the product, and the data pool all fire together, it leads revenue by a full season, and it is the exact thing a copycat starts at zero on.
| Sign | Green means |
|---|---|
| Free signups per week | 25 or more |
| Free-to-paid conversion (30 days) | above 5% (vs the 5.6% freemium median) |
| History piled up per practice | more than 3 items |
| Confirmed renewal dates on file | above 40% |
| Channel partners live | 3 or more |
| Local data-pool density | more than 5 filled cells |
| Checkout completion (the rail works) | above 85% |
| Practices still here after 60 days | above 80% (43% of small-biz losses hit in the first 90 days) |
Modeled math, bottom-up from the funnel: a green year one lands roughly $120K to $200K, exiting around $150K to $220K of run-rate. A green year two lands roughly $600K to $1.2 million, driven by expansion off the year-one base. The honest downside is named too (roughly $30K to $60K), and because the scoreboard shows it in weeks, the pivot stays cheap.